Contact this trialFirst, we need to learn more about you.
Nonsteroidal Anti-inflammatory Drug
Episcleral Celecoxib for Macular Edema
Recruiting1 awardPhase 1
Palo Alto, California
This trial is testing a treatment called Episcleral Celecoxib, which is applied to the outer layer of the eye. It is aimed at patients with macular edema and other inflammatory eye conditions. The drug works by reducing swelling and preventing harmful blood vessel growth in the eye. The main goal is to see if the treatment is safe and if it can improve vision by reducing inflammation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service